XML 164 R90.htm IDEA: XBRL DOCUMENT v3.2.0.727
Investment in equity investees (Details)
$ in Millions
 12 Months Ended
Mar. 31, 2015
USD ($)
Mar. 31, 2015
CNY (¥)
Mar. 31, 2014
CNY (¥)
Mar. 31, 2013
CNY (¥)
Cost method        
Balance at beginning of period   ¥ 13,589,000,000 ¥ 1,359,000,000 ¥ 1,316,000,000
Additions   12,304,000,000 12,655,000,000 392,000,000
Less: disposals and transfers   (9,818,000,000) (262,000,000) (99,000,000)
Less: impairment loss   (419,000,000) (119,000,000) (245,000,000)
Foreign currency translation adjustments   17,000,000 (44,000,000) (5,000,000)
Balance at end of period   15,673,000,000 13,589,000,000 1,359,000,000
Equity method        
Balance at beginning of period   4,077,000,000 196,000,000 326,000,000
Additions   16,518,000,000 3,908,000,000 190,000,000
Share of results and other comprehensive income   (1,148,000,000) (34,000,000) (14,000,000)
Less: disposals and transfers   (806,000,000)   (306,000,000)
Less: impairment loss   (438,000,000) 0 0
Foreign currency translation adjustments   1,000,000 7,000,000  
Balance at end of period   18,204,000,000 4,077,000,000 196,000,000
Total, cost and equity methods        
Balance at beginning of period   17,666,000,000 1,555,000,000 1,642,000,000
Additions   28,822,000,000 16,563,000,000 582,000,000
Share of results and other comprehensive income   (1,148,000,000) (34,000,000) (14,000,000)
Less: disposals and transfers   (10,624,000,000) (262,000,000) (405,000,000)
Less: impairment loss   (857,000,000) (119,000,000) (245,000,000)
Foreign currency translation adjustments   18,000,000 (37,000,000) (5,000,000)
Balance at end of period $ 5,465 33,877,000,000 17,666,000,000 1,555,000,000
Allocated Share-based Compensation Expense   13,028,000,000 2,844,000,000 ¥ 1,259,000,000
Equity investee with fair value adjustments of contingent consideration        
Total, cost and equity methods        
Fair value adjustment of contingent consideration   (68,000,000) ¥ 178,000,000  
Equity investee with share-based awards relating to Ant Financial Services        
Total, cost and equity methods        
Allocated Share-based Compensation Expense   ¥ 58,000,000